The Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.

The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have ...

ATTO-1310 offers a potential treatment for pruritic indications like CPUO where no approved treatments exist, and the potential for best-in-disease efficacy across pruritic conditions ...

In a Day 1 executive order, President Donald Trump withdrew from the landmark climate accord. Additional orders on energy are expected.

The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the ...

Privately owned Blue Origin has achieved its goal—a decade in the making—of becoming an orbital launch player, even as it ...

The ChristianaCare Health Network has officially become the second group of doctors and the first house staff in Delaware to ...

INOVIO (NASDAQ: INO) revealed its strategic milestones for 2025, positioning the company for significant advancements as it ...

New to Kayo? Get your first month for just $1. Limited time offer. Appo, 25, has spent the past two seasons playing with the Bradford Bulls in the second-tier RFL Championship in the UK.

The 25-year-old is due to appear at Bradford Magistrates' Court on Monday charged with rape. Appo is also accused of sexual assault on a female and two counts of assault. The forward plays ...